A 52-year-old man with hypertension and benign prostatic hyperplasia (BPH) is prescribed doxazosin 2 mg daily for both conditions. After 3 days, he presents to the emergency department with severe dizziness, blurred vision, and a syncopal episode. Examination: supine BP 145/90 mmHg, standing BP 95/55 mmHg; heart rate 110 bpm standing. Serum electrolytes and glucose are normal. ECG shows sinus tachycardia. Which of the following is the BEST immediate management?

Explanation

## Acute Management of Alpha Blocker–Induced Orthostatic Syncope **Key Point:** The immediate management of symptomatic orthostatic hypotension from alpha blockers is **volume expansion** (IV normal saline) and **postural support** (supine position with leg elevation). This restores venous return and cerebral perfusion without adding vasoconstrictors that may cause rebound hypertension. ### Pathophysiology of First-Dose Syncope This patient presents with **first-dose effect** from doxazosin: - Non-selective α1/α2 blockade → acute vasodilation - Loss of α2-mediated vasoconstriction and sympathetic feedback - Relative hypovolemia due to splanchnic and peripheral vasodilation - Compensatory tachycardia (HR 110) reflects sympathetic activation but fails to maintain MAP **High-Yield:** First-dose effect is most severe with non-selective agents (doxazosin, terazosin) and occurs within hours to days of starting therapy or increasing the dose. ### Why Each Management Option Works or Fails | Intervention | Mechanism | Appropriateness | Rationale | |--------------|-----------|-----------------|----------| | **IV saline + supine/leg elevation** | Restores preload → ↑ cardiac output → ↑ MAP | **BEST** | Addresses root cause (vasodilation + relative hypovolemia); safe; no rebound hypertension | | **Phenylephrine IV** | Direct α1 agonist → vasoconstriction | Avoid | Causes rebound hypertension; may precipitate stroke or MI; counterproductive | | **Switch to tamsulosin** | Uroselective; minimal orthostatic effect | Correct but NOT immediate | Appropriate long-term management; does not address acute syncope | | **Atropine** | Blocks muscarinic → ↑ HR | Inappropriate | No muscarinic involvement in α-blockade; does not restore BP | **Clinical Pearl:** Never use pure α-agonists (phenylephrine, noradrenaline) to treat alpha blocker–induced hypotension in the acute setting—they cause rebound hypertension once the alpha blocker wears off. Fluid resuscitation is the gold standard. ### Acute Management Algorithm ```mermaid flowchart TD A[Symptomatic orthostatic hypotension<br/>on alpha blocker]:::outcome --> B{Hemodynamically unstable?}:::decision B -->|Yes, syncope/altered mental status| C[Place supine,<br/>elevate legs]:::action C --> D[IV normal saline bolus<br/>500 mL–1 L]:::action D --> E[Recheck BP and symptoms<br/>in 10–15 min]:::action E --> F{Improved?}:::decision F -->|Yes| G[Admit for monitoring,<br/>hold alpha blocker]:::action F -->|No| H[Consider vasopressor only if<br/>refractory + ICU setting]:::urgent B -->|No, mild dizziness| I[Sit/lie down,<br/>oral fluids]:::action I --> J[Discharge with instructions:<br/>start at bedtime,<br/>titrate slowly]:::action ``` **Mnemonic:** **STOP & FLOW** for alpha blocker syncope: - **S**upine position - **T**hrow legs up (elevation) - **O**pen IV - **P**erfuse with saline - **F**luid resuscitation - **L**ow-dose alpha blocker restart (or switch to uroselective) - **O**bserve in hospital - **W**arn patient about first-dose effect ### Long-Term Management 1. **Hold doxazosin** until symptoms resolve (24–48 hours) 2. **Switch to uroselective alpha blocker** (tamsulosin 0.4 mg daily or alfuzosin 2.5 mg daily) 3. **Restart at bedtime** with slow titration 4. **Educate patient** on first-dose effect, rising slowly, and adequate hydration 5. **Monitor BP** supine and standing at follow-up **Tip:** In the exam, if you see "first-dose effect" + "syncope" + "alpha blocker," the answer is almost always **IV fluids + postural support**, not vasopressors.